OVERVIEW

The Cancer program at TRI brings together scientists and clinicians with a shared interest and expertise in cancers such as squamous cell carcinoma, breast cancer, prostate cancer, skin cancer, melanoma and metastatic disease.

Researchers use techniques that “mimic” human cancer pathogenesis to examine the establishment and progression of disease. This allows basic research investigations to be translated into clinical trials to address significant clinical questions, and potentially trial new therapies or diagnostics. Specialised cancer groups such as IHBI Cancer program led by Professor Judith Clements aims to understand more clearly the molecular and cellular basis for the development, progression, and metastasis of several cancers. This includes other hormone dependent cancers such as those of the reproductive and urogenital organs, breast, ovary, endometrium, and kidney, as well as skins, lung, blood, and head and neck cancers. melanoma and lung cancer.

Key Researchers
 
Andrew Perkins
Colleen Nelson
Geoffrey Faulkner
Ingrid Winkler
Jean-Pierre Levesque
John Hooper
Judith Clements
Kristen Radford
Maher Gandhi
Nicholas Andrew Saunders
Show More ...
CANCER RESEARCH PROGRAMS
Click a program below to learn more
 
Blood Cancer
Breast Cancer
Cervical Cancer
Head and Neck Cancer
Lung Cancer
Prostate Cancer
Skin Cancer
Event
Head and Neck Cancer Symposium 2018 Putting the person front and centre: Changing your clinical practice Join us for the 5th Biennial Head and Neck Cancer Symposium to be held at the Translational...Read more
Article
ASSC 2018 AWARD SCHEME The Australian Skin and Skin Cancer Research Centre (ASSC) 2018 Award Scheme is now open for applications. The 2018 ASSC Award aims to invest in one project that focuses on the...Read more
Article
Proving the link between High stress & a Poor immune System Proving the link between high stress and ill health and disease is becoming increasingly important particularly when it comes to...Read more
Article
Researchers show aspirin added to cancer drug improves effectiveness Adding aspirin to some existing cancer drugs could increase their effectiveness against a group of tumours resistant to treatment...Read more
Article
Dr Roberta Mazzieri wins funding from the cure brain cancer Five of Australia’s brightest researchers, including TRI based UQDI researcher Dr Roberta Mazzieri, can now focus solely on curing...Read more
Event
Brisbane Cancer Conference Welcome to the 3rd Brisbane Cancer Conference. With the establishment of the Brisbane Diamantina Health Partners, this meeting is an opportunity to draw together cancer...Read more
Event
Proton beam therapy: state-of-the-art technology to target cancer. Clinical outcomes and current status in Japan Presented by Tetsuo Akimoto, Head of the Department of Radiation Oncology and Particle...Read more
Event
TRI EMT and Cancer Treatment Symposium Leveraging on the availability of key national translational clinician researchers with EMT interests (Drs Andy Redfern, Elgene Lim), and particularly the head...Read more
Article
MATER RESEARCHER IDENTIFIES NEW INSIGHTS INTO BREAST CANCER TREATMENTS AND PROGNOSIS A Mater Research study 1 has identified a method to identify best treatment options for oestrogen receptor...Read more

Pages